BAY 1021189/15829: SOCRATES-PRESERVED: A randomized parallel-group, placebo-controlled, double-blind, multi-center dose finding phase II trial exploring the pharmacodynamic effects, safety and tolerability, and pharmacokinetics of four dose regimens of th

Project: Research project

Project Details

StatusFinished
Effective start/end date12/18/1312/18/16

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (BAY 1021189/15829)